Skip to main content
ISTH 2024 Main banner
Back

Hugo ten Cate, MD, PHD

MD, PhD
Departments of Internal Medicine and Biochemistry, Maastricht University Medical Center+, Maastricht, The Netherlands
Maastricht, Limburg, Netherlands

Hugo ten Cate
Graduated in medicine at the University of Amsterdam in 1987 and obtained a PhD degree based on an academic thesis on the Clinical and experimental studies with a low molecular weight heparinoid, at the University of Amsterdam in 1987. Between 1988 and1990 he was a postdoctoral fellow at the laboratory of prof Robert D Rosenberg and dr. Kenneth A Bauer, Beth Israel Hospital and Harvard Medical School Boston where he studied mechanisms of thrombosis using novel coagulation activation markers. Next, he completed training in Internal medicine at Slotervaart hospital and Academic Medical Center Amsterdam, combining it with translational research at Sanquin (prof Erik Hack) and at the Academic Medical Center (laboratory of Experimental Internal medicine, prof Pieter Reitsma). After being awarded a Clinical Established Investigatorship from the Dutch Heart Foundation he joined the Maastricht University Medical Center (MUMC+) and Cardiovascular Research Institute (CARIM) in 2002 as a Principal investigator and Professor in Internal medicine, particularly in Clinical Thrombosis and Haemostasis. He is the Director of the Maastricht Thrombosis Expertise Center, at the Heart and Vascular Center, MUMC+, a staff member of the division of Vascular Medicine, dept. of Internal medicine and Division leader Blood and board member CARIM. Between 2012 and 2016 he was a Fellow of the Gutenberg Research College, Gutenberg University and since 2017 Adjunct-professor, Center for Thrombosis and Haemostasis (CTH), Gutenberg University Medical Center, Mainz, Germany.
He is member of editorial boards of Thrombosis and Haemostasis (section editor), Journal of Thrombosis and Hemostasis, ATVB, Eur J Internal Med and chief specialty editor Thrombosis and Hemostasis Section of Frontiers in Cardiovascular Medicine.
His main line involves thrombo-inflammatory pathway analysis in thrombotic diseases, which he explores in translational research within several (inter)national consortia. He has supervised over 70 PhD students and (co-) authored over 600 articles.

Presentation(s):